Gastroenterology & Hepatology

Veronica TenCate, DO
Assistant Professor
Doctor of Osteopathic Medicine (DO)
2005: Midwestern University; Chicago College of Osteopathic Medicine
Residency
2005-2008: University of Illinois at Chicago, Chicago, IL
Fellowship
2008-2011: Gastroenterology, University of Illinois at Chicago, Chicago, IL
Transplant Hepatology Fellowship
2011-2012: University of Illinois at Chicago, Chicago, IL

 Clinical Interests & Patient Appointments

PUBLICATIONS (To view complete Curriculum Vitae, click here)

Manuscripts

1. Hulin MS, Wakefield TW, Andrews PC, Wrobleski SK, Stoneham MD, Doyle AR, Zelenock GB, Jacobs LA, Shanley CJ, TenCate VT, Stanley JC. A Novel Protamine Variant Reversal of Heparin Anticoagulation in Human Blood In Vitro.  J Vasc Surg 1997 Dec:26(6): 1043-8.
    
2. Cotler SJ, Kallwitz E, TenCate V, Bhushan A, Berkes J, Benedetti E, Layden-Almer J, Layden TJ, Valyi-Nagy T,Guzman G. Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation. Transplantation. 2007 Sep 15;84(5):587-91.
    
3. Kallwitz ER, Guzman G, TenCate V, Vitello J, Layden-Almer J, Berkes J, Patel R, Layden TJ, Cotler SJ. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol. 2009 Jan;104(1):64-9.
    
4. TenCate V, Sainz BJ, Uprichard S. Three dimensional Huh7 cell culture system for the study of Hepatitis C Virus. Virology Journal. 15 Jul 2009: 6:1 (103).
    
5. TenCate VM, Cotler S. Antiviral therapy as an adjunct to passive-active immunotherapy or perinatal transmission of HBV. Current Hepatitis Reports.  Vol 8 Num3 August 2009.
    
6. TenCate V, Sainz B, Cotler S, Uprichard S. Potential treatment option and future research to increase hepatitis C virus treatment response rate. Hepatology Med. 2010 Oct;2010(2):125-145.

Abstracts

1. TenCate V, Sainz Jr B, Uprichard S. Development of a Novel Three-Dimensional Differentiated Huh7 Cell Culture System for the Study of HCV Infection and Pathogenesis.  HCV International Meeting, DDW 2009 and UIC Research Symposium.
    
2. Kallwitz E, TenCate V, Guzman G, Vitello J, Berkes J, Layden T, Cotler S. The performance of clinical models to predict NASH and advanced fibrosis in obesity surgery patients.  AASLD 2009, abstract 1047.
    
3. TenCate, V, Layden J, Johnson K, Wolfert M, Cotler S. and Layden T. Paired Biopsies Show Racial Differences in Fibrosis Progression in Patients with Hepatitis C. Boston AASLD 2009, abstract 1629 and UIC Research Symposium.
    
4. TenCate V, Mettu P, Ovrahim K, Yue H, Kallwitz E and Colter C. Correlates of the Timing of Weight Gain, Obesity, and the Metabolic Syndrome After Liver Transplant.  AASLD 2011 and Advocate Liver Abstract Competition 2011. Hepatology Oct 201, 54(4) Suppl 654A; 604.
    
5. Kallwitz, ER, TenCate V, Mettu PS, Ovrahim K, Huang Y, Walzer N, Berkes JL, Layden TJ, Colter SJ. Elevated Serum Creatinine and the Metabolic Syndrome are Associated with Major Vascular Events After Transplantation.  Presented at AASLD. Hepatology Oct 2011, 54(4) Suppl 641A; 574.